Watchlist Price Alert

EyePoint Pharmaceuticals ... (EYPT)

NASDAQ: EYPT · Real-Time Price · USD

8.81

-0.09 (-1.01%)

At close: Jun 17, 2025, 3:59 PM

8.50

-3.57%

After-hours: Jun 17, 2025, 07:33 PM EDT

EyePoint Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Cash & Equivalents	99.7M	281.26M	95.63M	178.59M	44.91M	22.21M	38.78M	16.9M	15.31M
Short-Term Investments	271.21M	49.79M	48.93M	32.97M	n/a	n/a	n/a	n/a	13.68M
Long-Term Investments	n/a	150K	150K	150K	150K	150K	150K	n/a	150K
Other Long-Term Assets	5.98M	n/a	1.36M	626K	150K	507K	150K	260K	264K
Receivables	607K	805K	15.5M	18.35M	9.45M	11.37M	353K	353K	251K
Inventory	2.31M	3.91M	2.89M	3.62M	5.34M	2.14M	-353K	-251K	-488K
Other Current Assets	1.41M	1.01M	9.86M	4.22M	3.42M	n/a	1.13M	n/a	n/a
Total Current Assets	383.31M	344.8M	172.81M	237.75M	63.12M	42.07M	39.91M	17.74M	29.96M
Property-Plant & Equipment	29.18M	10.23M	6.04M	2.25M	3.24M	3.08M	253K	313K	290K
Goodwill & Intangibles	n/a	n/a	n/a	22.75M	25.21M	27.67M	31.36M	364K	1.1M
Total Long-Term Assets	35.16M	10.38M	7.55M	25.63M	28.6M	31.25M	31.76M	937K	1.66M
Total Assets	418.46M	355.18M	180.36M	263.37M	91.72M	73.32M	71.67M	18.68M	31.62M
Account Payables	11.72M	6.5M	5.92M	7.38M	4.81M	4.19M	2.64M	2.94M	1.02M
Deferred Revenue	17.78M	38.59M	1.21M	1.07M	945K	15K	30K	50K	147K
Short-Term Debt	n/a	n/a	10.47M	n/a	n/a	481K	n/a	n/a	n/a
Other Current Liabilities	13.27M	5.54M	6.09M	5.58M	5.69M	3.09M	15M	-14.61M	2.59M
Total Current Liabilities	49.05M	63.26M	34.54M	23.66M	14.89M	11.87M	21.66M	5.29M	5.09M
Long-Term Debt	n/a	n/a	29.31M	36.56M	37.98M	47.22M	17.31M	17.31M	n/a
Other Long-Term Liabilities	205K	n/a	600K	2.35M	2.37M	3M	21.01M	-17.26M	51K
Total Long-Term Liabilities	32.92M	25.6M	49.45M	55.33M	58.29M	53.12M	38.32M	51K	5.64M
Total Liabilities	81.96M	88.86M	83.99M	78.99M	73.18M	64.99M	59.98M	5.34M	10.74M
Total Debt	21.86M	4.91M	45.77M	38.42M	40.31M	50.6M	17.31M	17.31M	n/a
Common Stock	68K	49K	766.93M	752.64M	528.38M	472.78M	374.84M	323.32M	312.24M
Retained Earnings	-873.02M	-742.15M	-671.35M	-569.1M	-510.68M	-465.29M	-363.99M	-310.82M	-292.21M
Comprehensive Income	1.03M	864K	786K	841K	841K	840K	838K	833K	852K
Shareholders Equity	336.5M	266.32M	96.37M	184.38M	18.54M	8.33M	11.69M	13.34M	20.88M
Total Investments	271.21M	49.94M	48.93M	32.97M	150K	150K	150K	n/a	13.68M